ANI Pharma to List Through Takeover of BioSante

Unlisted ANI Pharmaceuticals Inca, a speciality and generic pharmaceutical company is listing through the purchase of BioSante Pharmaceuticals, another drugmaker, in an all-stock deal.

BioSante will issue stock to ANI shareholders giving ANI stockholders a 53% stake in the combined company.

The combined company will be renamed ANI Pharmaceuticals and be led by the ANI management team, with Arthur Przybyl serving as chief executive officer, the companies said in a joint statement.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.